Do they take into the army with tachycardia of the heart, myocardial infarction, sinus tachycardia

Military service is inextricably linked to constant physical activity, which directly affects the heart rate. Is it possible in the process of examination to identify pathology and is it taken in the army with tachycardia of the heart? Questions are frequent and relevant.

First of all, in the course of a commission examination for the suitability of a conscript for service, it is quite problematic to identify tachycardia. The increase in heart rate is noticeable only by the results of the cardiogram of the heart. Therefore, in assessing the suitability of a conscript, a medical record with records of the presence of chronic diseases is also subject to assessment.

For this commission inspection you have to require an additional examination. It is also possible in a situation in which the initiative to undergo such an examination comes from the commission, if it is impossible to give an opinion in the framework of the usual.

According to the results, a conclusion is drawn on the suitability or unfitness for service with the assignment of a certain category.

Much depends on the severity of a disease. For example, draftees with the same diagnosis can be sent to the army with different categories of fitness for service, which are divided as follows:

  • “A” is valid;
  • “B” – is suitable with some restrictions;
  • “B” – sent to stock;
  • “G” – temporarily unsuitable;
  • “D” is unsuitable.

If, according to the diagnostic results, sinus tachycardia without concomitant diseases was confirmed, then the young man will be taken into the army, taking into account the limitations on physical activity. If, in addition to tachycardia, other pathologies of the cardiovascular system were found, then due to the high risks of poor health, the conscript will be completely released from service or sent to the reserve.

Detonic – a unique medicine that helps fight hypertension at all stages of its development.

Detonic for pressure normalization

The complex effect of plant components of the drug Detonic on the walls of blood vessels and the autonomic nervous system contribute to a rapid decrease in blood pressure. In addition, this drug prevents the development of atherosclerosis, thanks to the unique components that are involved in the synthesis of lecithin, an amino acid that regulates cholesterol metabolism and prevents the formation of atherosclerotic plaques.

Detonic not addictive and withdrawal syndrome, since all components of the product are natural.

Detailed information about Detonic is located on the manufacturer’s page www.detonicnd.com.

Perhaps you want to know about the new medication - Cardiol, which perfectly normalizes blood pressure. Cardiol capsules are an excellent tool for the prevention of many heart diseases, because they contain unique components. This drug is superior in its therapeutic properties to such drugs: Cardiline, Recardio, Detonic. If you want to know detailed information about Cardiol, go to the manufacturer’s website.There you will find answers to questions related to the use of this drug, customer reviews and doctors. You can also find out the Cardiol capsules in your country and the delivery conditions. Some people manage to get a 50% discount on the purchase of this drug (how to do this and buy pills for the treatment of hypertension for 39 euros is written on the official website of the manufacturer.)Cardiol capsules for heart
Svetlana Borszavich

General practitioner, cardiologist, with active work in therapy, gastroenterology, cardiology, rheumatology, immunology with allergology.
Fluent in general clinical methods for the diagnosis and treatment of heart disease, as well as electrocardiography, echocardiography, monitoring of cholera on an ECG and daily monitoring of blood pressure.
The treatment complex developed by the author significantly helps with cerebrovascular injuries and metabolic disorders in the brain and vascular diseases: hypertension and complications caused by diabetes.
The author is a member of the European Society of Therapists, a regular participant in scientific conferences and congresses in the field of cardiology and general medicine. She has repeatedly participated in a research program at a private university in Japan in the field of reconstructive medicine.

Detonic